Heterologous immunization strategies combining subunit or DNA and MVA-based vaccines expressing VP7 induced an antigen-specific CD8+ T cell response, slowed down disease progression and viral replication at initial stages of infection, but were unable to protect immunized animals against BTV (34, 39, 50–52). This evidence concerns the gene CD8A and infection.